Gene · 4038
Papers1,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neuronal injury and hepatotoxicity: astrocytes and stellate cells convergence and their role in tissue repair. | Front Neurosci | 2025 | 41710466 | PubTator, text mining | PubMed |
| WNT10A-SMOC2-LRP4 network affects permanent tooth development via potential tooth-bone interaction. | BMC Oral Health | 2025 | 41408627 | PubTator, text mining | PubMed |
| Coexistence of Acute Demyelinating Polyneuropathy and LRP4-Positive Myasthenia Gravis. | Case Rep Neurol Med | 2025 | 41126943 | PubTator, text mining | PubMed |
| Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now? | Brain Sci | 2025 | 41008338 | PubTator, text mining | PubMed |
| A Rare Case of Juvenile Myasthenia Gravis With Low-Density Lipoprotein Receptor-Related Protein 4 Antibodies in a Seven-Year-Old Boy. | Pediatr Neurol | 2025 | 40945202 | PubTator, text mining | PubMed |
| Neuron-specific Agrin splicing by Nova RNA-binding proteins regulates conserved neuromuscular junction development in chordates. | PLoS Biol | 2025 | 40938937 | PubTator, text mining | PubMed |
| Cauda equina nerve root enhancement in adult intestinal toxemia botulism. | BMC Neurol | 2025 | 40847385 | PubTator, text mining | PubMed |
| Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition. | Exp Hematol Oncol | 2025 | 40847323 | PubTator, text mining | PubMed |
| Plasma Biomarkers of Mitochondrial Dysfunction in Patients with Myasthenia Gravis. | Med Sci (Basel) | 2025 | 40843740 | PubTator, text mining | PubMed |
| FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia. | Antibodies (Basel) | 2025 | 40843677 | PubTator, text mining | PubMed |
| Factors Influencing Quality of Life in Myasthenia Gravis Patients: Results From a Cross-Sectional Study in South of Iran. | Brain Behav | 2025 | 40842108 | PubTator, text mining | PubMed |
| Diffuse Osteosclerosis in a Young Cat Presenting With Chronic Nasal Congestion: A Case Report. | Vet Med Sci | 2025 | 40833355 | PubTator, text mining | PubMed |
| The efficacy and safety of efgartigimod for refractory myasthenia gravis: a systematic review and meta-analysis. | Eur J Med Res | 2025 | 40830529 | PubTator, text mining | PubMed |
| Clinical utility of autoantibodies in the diagnosis and management of Myasthenia gravis. | J Neuroimmunol | 2025 | 40795619 | PubTator, text mining | PubMed |
| The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer. | Theranostics | 2025 | 40771583 | PubTator, text mining | PubMed |
| National guidelines for diagnosis, treatment, and management of myasthenia gravis in Israel. | Ther Adv Neurol Disord | 2025 | 40766205 | PubTator, text mining | PubMed |
| Immune Modulatory Effects of PD-1/PD-L1 in Myasthenia Gravis: Insights From Peripheral Blood Mononuclear Cell Analysis. | FASEB J | 2025 | 40748491 | PubTator, text mining | PubMed |
| Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases. | Hum Vaccin Immunother | 2025 | 40747591 | PubTator, text mining | PubMed |
| Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction. | Neurol Neuroimmunol Neuroinflamm | 2025 | 40743488 | PubTator, text mining | PubMed |
| Autoantibodies in myasthenia gravis. | Int Rev Neurobiol | 2025 | 40675742 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4038/papers?page=4